News for TAPIMMUNE INC (TPIV)

News for TAPIMMUNE INC
Date Headline
Apr 11, 2018 07:10 AM Blog Exposure - GTx Completed Patient Enrollment Several Months Ahead in the Phase-2 Clinical Trial of Enobosarm in SUI
Apr 05, 2018 04:05 PM TapImmune Provides Fourth Quarter and Year-End 2017 Corporate and Clinical Update
Mar 29, 2018 06:30 AM TapImmune to Provide Fourth Quarter and Full Year 2017 Business Update Conference Call and Webcast
Mar 28, 2018 06:30 AM TapImmune to Present at The MicroCap Conference
Mar 15, 2018 08:31 AM TapImmune shares surge 17% on early-stage vaccine results
Mar 15, 2018 08:00 AM TapImmune Announces Publication of Clinical Trial Results for the TPIV200 Cancer Vaccine in Clinical Cancer Research
Mar 14, 2018 06:30 AM TapImmune to Present at Two Upcoming Investor Conferences
Feb 06, 2018 06:30 AM TapImmune to Participate in Two Upcoming Investor Conferences
Jan 03, 2018 06:30 AM TapImmune to Present at Biotech Showcase™ 2018
Dec 19, 2017 10:35 AM How Does TapImmune Inc (NASDAQ:TPIV) Compare To The Healthcare Sector?